Association of metformin with risk of digestive tract cancers from a drug target mendelian randomization and cell experiments
Abstract Background Digestive tract cancers account for a significant proportion of the global cancer burden, and their prevention and treatment pose a worldwide challenge. Metformin, as a first-line treatment for diabetes, offers advantages such as high safety and affordability. Previous research h...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer
2025-05-01
|
| Серии: | Discover Oncology |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1007/s12672-025-02729-3 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|